Navigation Links
Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
Date:9/11/2008

forward to further progress in this program."

Based on the results of the SUPPORT study, Cerimon intends to initiate its Phase III program of the diclofenac patch by early 2009.

Acute Pain

Musculoskeletal pain is pain that affects the muscles, ligaments, tendons and bones. Acute musculoskeletal injuries are common and can occur during sports activities, exercise or other physical activities. Acute musculoskeletal injuries generally require rapid treatment, which often includes the administration of anti-inflammatory drugs. Optimal topical treatment should relieve acute pain and reduce swelling in the injured area to restore normal movement. In addition, it should be safe and easy to administer.

Pain Market

Pain represents a large and dynamic market in the United States. Oral formulations of non-steroidal anti-inflammatory drugs (NSAID) currently are marketed worldwide for the treatment of inflammation and pain, including pain due to musculoskeletal injuries, signs and symptoms of osteoarthritis and rheumatoid arthritis, menstrual cramps, headache and other minor aches and pains. While traditional oral NSAIDs are effective, they can cause serious gastrointestinal and cardiovascular adverse events. Further, the withdrawal of some COX-2 inhibitors, a class of NSAIDs, has removed a major therapeutic option for patients with multiple moderate and severe forms of pain, resulting in a significant market opportunity. These developments have created an important need for a localized pain product with a strong safety profile.

About Cerimon Pharmaceuticals

Cerimon Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutic products for autoimmune diseases, inflammation and pain. Cerimon believes these new treatment options will enable physicians specialized in treating these conditions to further improve the lives of their patients.

Cerimon currently has two drugs in multi
'/>"/>

SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
3. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
4. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
5. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
6. Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
7. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
8. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
9. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
10. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
11. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... England , April 17, 2015 ... genomics company announced today that their presence at the 2015 ... include a presentation by co-founder Nitzan Rosenfeld and ... also attending April 18 th - 22 nd . ... in plasma using ctDNA , forms part of ...
(Date:4/17/2015)... 17, 2015 ASSESS shows   ... is a viable alternative to tumour biopsy   ... patients with advanced NSCLC   AstraZeneca today presented ... circulating tumour DNA (ctDNA) testing for epidermal growth factor receptor ... cell lung cancer (NSCLC) in clinical practice. [ 1 ...
(Date:4/17/2015)... , April 17, 2015  Over the next five years, ... to grow, with ArcView predicting that 14 more states will ... marijuana. The U.S. market for legal cannabis grew 74 percent ... 2013. Analysts project the market could grow more than fourfold ... states soften their stance on marijuana. Cannabiz Mobile ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Healthcare Conference on Friday, September 17, 2010 at 8:35 a.m. ... the Four Seasons in Boston.  Steve Worland, Ph.D., President and ... Anadys and its clinical development programs. Dr. Worland ...
... SYK ) announced that it will host a ... Eastern Time, to discuss the Company,s operating results for the ... Operating results for the quarter ended September 30, 2010 will ... participate in the conference call dial 866-270-6057(domestic) or ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Stryker to Host Conference Call on October 19, 2010 2
(Date:4/19/2015)... Autocarinsurancecheap.com has released a new blog post ... protection for vulnerable family members. , Accidental death ... or is disabled in an accident. The policy will ... an auto insurance plan. However, AD&D insurance can also ... life insurance policy. The newly blog post presents the ...
(Date:4/19/2015)... Carinsurancesavings.biz has released a new blog post explaining ... who have diabetes. , Clients who have diabetes ... newly released blog post explains how diabetes influences auto ... low cost coverage. , It is now possible ... single website. Clients can visit http://carinsurancesavings.biz for ...
(Date:4/19/2015)... 19, 2015 McCann Investigations, a Texas-based ... the publication of white paper Married, but Dating: ... As online media provides a unique environment of privacy, ... specifically targeting adulterous spouses has emerged. Social platforms ... as easy as shopping online. Dating sites and ...
(Date:4/18/2015)... York, NY (PRWEB) April 19, 2015 ... experienced strong growth during the past five years. The ... individuals who are unable to fully care for themselves, ... the growing need for dementia care for seniors with ... to rise at an annualized rate of 4.1% to ...
(Date:4/18/2015)... "I recognized the need for a better ... an inventor from Cincinnati, Ohio. "This need inspired me ... the Slyde Door to offer an alternative to the ... provides convenient storage space for an evacuation stretcher. The ... patients. , This offers added peace of mind ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Finding Low Cost Auto Insurance for Diabetic Drivers! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... 10 Mark Ganz, President and Chief,Executive Officer of ... of,thought leaders and health policy experts convened by The ... reframe and broaden the,national dialogue on health care reform ... The Aspen Health Stewardship Project will expand the health ...
... Women under the age of forty with breast cancer who ... as adjuvant chemotherapy, may not be benefiting from these drugs. ... levels of hormones such as estrogen, according to research published ... cancer at a young age is very worrying in terms ...
... urges Congress to,pass legislation this year to ... WASHINGTON, Oct. 10 The Health IT ... and former,Representative Nancy Johnson, today applauded Representatives ... that will bring health,information technology to all ...
... Oct. 10 XShares Advisors LLC, on behalf ... 12-month supporting,relationship with the Parkinson,s Disease Foundation (PDF), ... public advocacy. XShares, platinum level support of ... and Clinical Advances in Quality of Life,and exclusive ...
... an investment,company with a family of 20 fund portfolios, ... of its 19 currently NYSE-listed,HealthShares exchange-traded funds (ETFs) to ... requirement to transfer of all ETFs to the,NYSE Arca ... prior to,October 31, 2007. The transfer is expected to ...
... SpectraScience, Inc. (OTC,Bulletin Board: SCIE) announced today ... of the Company,s quality system from the Notified,Body ... reference to,Annex II.3 of the European directive 93/42/EEC. ... issued. Jim Hitchin the Company,s CEO said, ...
Cached Medicine News:Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Cancer conflict with chemotherapy treatment 2Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 3Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 4Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4Health News:SpectraScience Receives Final European Certification 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: